U
MED icon

UBS’s Medifast MED Stock Holding History

UBS’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,000
Closed -$29K – 10651
2014
Q1 		$29K Hold
1,000
– – ﹤0.01% 7590
2013
Q4 		$26K Buy
1,000
+300
+43% +$7.69K ﹤0.01% 7817
2013
Q3 		$19K Buy
700
+600
+600% +$16K ﹤0.01% 8129
2013
Q2 		$3K Buy
+100
New +$2.63K ﹤0.01% 9614

Other funds holding MED

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GGPE
Golden Gate Private Equity San Francisco, California $241M AUM 13.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS's MED Position: Q3 2014 in Review

UBS increased its Medifast (MED) stake by 4.1% in Q3 2014, buying an estimated $5.03K and bringing the position to 4,146 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #5602.

UBS first reported a position in MED in Q2 2013 and has held it in 6 quarters since. 124 funds tracked by Wall St. Rank hold MED as of Q3 2014.

  • UBS held 4,146 shares of Medifast worth $136K as of Q3 2014.
  • UBS bought 164 Medifast shares in Q3 2014, an estimated $5.03K.
  • Medifast made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5602 holding.
  • UBS first reported a position in Medifast in Q2 2013 and has held it in 6 quarters since.
  • 124 funds tracked by Wall St. Rank held Medifast as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.